Dolutegravir/Lamivudine Efficacy and Safety Outcomes in People With HIV-1 With or Without Historical Resistance Results at Screening: 48-Week Pooled Analysis.
Saved in:
| Title: | Dolutegravir/Lamivudine Efficacy and Safety Outcomes in People With HIV-1 With or Without Historical Resistance Results at Screening: 48-Week Pooled Analysis. |
|---|---|
| Authors: | Scholten, Stefan1 (AUTHOR), Cahn, Pedro2 (AUTHOR), Portilla, Joaquín3 (AUTHOR), Bisshop, Fiona4 (AUTHOR), Hodder, Sally5 (AUTHOR), Ruane, Peter6 (AUTHOR), Kaplan, Richard7 (AUTHOR), Wynne, Brian R8 (AUTHOR), Man, Choy Y8 (AUTHOR), Grove, Richard9 (AUTHOR), Wang, Ruolan8 (AUTHOR), Jones, Bryn10 (AUTHOR), Ait-Khaled, Mounir10 (AUTHOR), Kisare, Michelle10 (AUTHOR) michelle.o.kisare@viivhealthcare.com, Okoli, Chinyere10 (AUTHOR) |
| Source: | Open Forum Infectious Diseases. Jul2024, Vol. 11 Issue 7, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 23288957 |
|---|---|
| DOI: | 10.1093/ofid/ofae365 |
